Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broccoli Seed and Sprout Extract for Detoxification of Tobacco Carcinogens in Heavy Smokers
NCT05121051Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in smoking-related carcinoma comparing Group I (broccoli seed and sprout extract) with Group II (placebo) (2 arms). Primary endpoint: Detoxification of benzene and acrolein at 12 weeks. Started Sep 2022; status: recruiting.
02
Drugs
broccoli seed and sprout extract
03
Conditions
smoking-related carcinoma
Beyond the preview
Go deeper on NCT05121051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05121051.